新的 mRNA 疗法通过改善小鼠的胎盘血管,显示出治疗先兆子痫的希望。 New mRNA therapy shows promise in treating pre-eclampsia by improving placental blood vessels in mice.

研究人员开发了一种以MRNA为基础的疗法,通过改善胎盘的血管生长,减少与该病症有关的高血压,成功地治疗小鼠的先兆子痫。 Researchers have developed an mRNA-based therapy that successfully treats pre-eclampsia in mice by improving blood vessel growth in the placenta, reducing high blood pressure associated with the condition. 子宫前怀孕是严重的妊娠并发症,在全球造成大量孕产妇和胎儿死亡。 Pre-eclampsia, a serious pregnancy complication, causes significant maternal and fetal deaths globally. 人类试验虽然很有希望,但对于确定治疗的功效和安全性是必要的。 While promising, human trials are necessary to determine the therapy's efficacy and safety.